crooks will try to push it down after the initial rise, it's what they do. If ACHN has any new and successful clinical trial info, that's when the real fun with shorts will begin. We "could" see a high-volume run to the mid teens or $20 IMO on successful phase II data.
report looks positive, cash is very high, new read out in Hep C not far off, new clinical trials started, what's not to like? Should be $10 soon in a decent market.
being better than JL is a very low bar, or high depending on whether you are going under, or over. JL was a terrible communicator, whether he was excited, or not.
The ABBV Hep C drug combo has a tox warning, the GILD drug has a new issue, slow heartbeat patients passing out. Are there any alternatives? Hmmm.
I heard nothing about ATM, they did mention maintaining liquidity, which should be easy considering their hedges if they could operate better. They are sitting at 0-2, 3 strikes and they are out. And still, I'm buying more. Why do I do it?
I sent a scathing email and bought more stock. It's a value here if/when management gets their act together. This is really unacceptable. Operations is the easiest thing to fix. Hire someone that can operate, design and implement world class processes, eliminate waste, bingo.
hire a strong operations leader, reduce corporate overhead, consolidate with a well run firm, stop giving out stock to poorly performing execs who seem too focused on their personal returns.
Pumping in CA has increased the risk profile IMO. They better have great quality and operating controls.
also, this celebrity link can help to move the development process forward more rapidly and help valuations.
a strong operating firm like BBEP need to buy this firm and show them how to run the business. Maybe someone else will step in now if this acquisition was so good. Drilling oil in CA sounds risky to me, they are all environmental fanatics.
Robin Williams and over 1MM people had/have the indication for which ARNA's recently licensed drug is being tested. Also the indication and type of drug are not significantly different from ACAD, so I think they have a good/reasonable shot at success.
As S9 said 2 years ago, ACAD should buy ARNA.